Reduced cost of managing exacerbations with stable dose treatment with salmeterol/fluticasone (SFC) compared with adjustable maintenance dosing (AMD) with formoterol/budesonide (FBC)

BACKGROUND: The high cost of asthma care is largely attributed to poor control of disease, in particular the treatment of exacerbations. METHOD: A 1-year, randomised, double blind, double dummy study in adult asthmatics currently receiving >500–1000mcg ICS or 200–500mcg ICS+LABA daily. Both AMD a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prim Care Respir J
Main Authors: Pieters, Willem R., Williams, Angela E., Follows, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2005
Assuntos:
Abstact
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6743588/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pcrj.2005.06.006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados